These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature. Marshall K; Klepeiss SA; Ioffreda MD; Helm KF Cutis; 2010 Mar; 85(3):137-40. PubMed ID: 20408512 [TBL] [Abstract][Full Text] [Related]
3. Treatment of scleromyxedema with intravenous immunoglobulin. Roque Diamantino Fde E; Lopes João AM; Clemente Fidalgo AI; Taveira Lobo Mde L Eur J Dermatol; 2010; 20(6):861-2. PubMed ID: 20956104 [No Abstract] [Full Text] [Related]
4. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis? do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910 [No Abstract] [Full Text] [Related]
5. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema. Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421 [No Abstract] [Full Text] [Related]
6. Self-healing juvenile cutaneous mucinosis manifesting with subcutaneous nodules. Nanda A; Selim MK; Al-Sabah H; Singhal V; Kapila K Indian J Dermatol Venereol Leprol; 2010; 76(2):198-9. PubMed ID: 20228561 [No Abstract] [Full Text] [Related]
14. Scleromyxedema, a positive effect with thalidomide. Jacob SE; Fien S; Kerdel FA Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous resolution of facial papular mucinosis in a transplant patient. Braue A; Dolianitis C; Varigos G Australas J Dermatol; 2008 Aug; 49(3):164-6. PubMed ID: 18638226 [TBL] [Abstract][Full Text] [Related]
16. Scleromyxoedema. van Leersum F; Abdul Hamid M; Steijlen P Lancet; 2017 Apr; 389(10078):1549. PubMed ID: 27894593 [No Abstract] [Full Text] [Related]
17. End-stage disease of native kidneys in a patient with biopsy-proven Arndt-Gottron scleromyxoedema and recurrence in the transplanted kidney. Peeters P; Praet M; Van Vlem B; Naeyaert JM; Vanholder R Nephrol Dial Transplant; 2007 Oct; 22(10):3065-9. PubMed ID: 17616537 [TBL] [Abstract][Full Text] [Related]
18. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. Rey JB; Luria RB J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema]. Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699 [TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature. Sroa N; Campbell S; Bechtel M J Drugs Dermatol; 2010 Mar; 9(3):263-5. PubMed ID: 20232589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]